Dr. Patrick Kai-Ming McCabe, MD

Dr. McCabe practices at Endoscopy Center of South Sacramento in Sacramento, California.

Dr. McCabe's NPI, 1659798650, was assigned on March 27, 2014. Dr. McCabe graduated from Heersink School of Medicine - Birmingham in 2014. Dr. McCabe holds California license A139679.

Dr. McCabe's primary practice is Endoscopy Center of South Sacramento, at 8120 Timberlake Drive #103, Sacramento, CA 95823. The practice phone is (916) 681-2350.

Dr. McCabe's primary practice is Endoscopy Center of South Sacramento in Sacramento, California. Dr. McCabe is also affiliated with Dignity Health - Mercy General Hospital. The medical group on file is Mercy Medical Group. Dmand AI also links Dr. McCabe to 3 more hospitals, 2 ambulatory surgery centers, 2 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. McCabe practices, 8 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. McCabe's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. McCabe is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. McCabe's licenses on file in 2 states: California and Nevada.

Dmand AI lists acid reflux, chronic inflammatory bowel disease (IBD), colonoscopy, gastroenteritis, gastrointestinal bleeding, hemorrhoids, irritable bowel syndrome (IBS) and upper GI endoscopy among the conditions Dr. McCabe treats.

CMS data shows 480 Medicare services from Dr. McCabe across 13 procedure codes in 2024, for 260 Medicare patients. Medicare paid $52,321 for them.

CMS counts 260 Medicare patients who saw Dr. McCabe in 2024. The largest group is 65 to 74, with 125 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 52% are also on Medicaid. Their average risk score is 1.75, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. McCabe's median patient age at 58, with 55% women.

In 2024, Dr. McCabe wrote 335 Medicare Part D claims for 174 patients. 85% of them were for generic drugs. CMS names the drug for 242 of them, across 7 drugs with 11 or more claims each, at $5,020 in total drug cost. In 2023, CMS named 194 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. McCabe for performance year 2024, reported through an alternative payment model (APM). Dr. McCabe accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. McCabe as offering telehealth. CMS counts 75 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. McCabe, more than 71% of the clinicians it reports for that procedure.

Dmand AI links 9 papers to Dr. McCabe, published from 2017 to 2022. 2018 was the busiest year, with 2. The most frequent topics are Liver Transplantation, End Stage Liver Disease and Karnofsky Performance Status. Dr. McCabe has published most often in Clin Gastroenterol Hepatol. Dr. McCabe's most frequent co-authors are Artin Galoosian, MA, MD, Nikhil Agarwal, MD and Ramsey Cheung, MD.

CMS Open Payments shows 161 general payments to Dr. McCabe from 18 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 95% of the total. Abbvie Inc. paid the most, $1,132.

Dr. McCabe graduated from Heersink School of Medicine - Birmingham in 2014.

Dr. McCabe is in network with 14 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.